Spero Therapeutics Inc (SPRO)

전일 마감가:

$1.61

열려 있는:

$1.63

하루 거래량:

52,814

시가총액:

$88.11M

수익:

$76.19M

순이익/손실:

$-1.61M

주가수익비율:

-6.2885

EPS:

-0.26

순현금흐름:

$28.98M

1주 성능:

+11.99%

1개월 성능:

-8.66%

6개월 성능:

+37.39%

1년 성능:

-9.67%

1일 변동 폭

$1.62

$1.6494

52주 변동 폭

$0.99

$1.995

Spero Therapeutics Inc Stock (SPRO) Company Profile

명칭

Spero Therapeutics Inc

부문

Healthcare (1223)

산업

Biotechnology (681)

전화

857 242 1600

주소

675 Massachusetts Avenue, 14th Floor, Cambridge, MA

직원

41

트위터

@spero_tx

다음 수익 날짜

2024-05-09

최신 SEC 제출 서류

SPRO's Discussions on Twitter

Spero Therapeutics Inc Stock (SPRO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-09-23	업그레이드	Evercore ISI	In-line → Outperform
2021-10-01	다운그레이드	Oppenheimer	Outperform → Perform
2021-01-22	재확인	H.C. Wainwright	Buy
2020-12-16	개시	Berenberg	Buy
2020-09-29	개시	Evercore ISI	Outperform
2019-11-05	재확인	H.C. Wainwright	Buy
2019-09-09	개시	Janney	Buy
2018-02-09	개시	Cantor Fitzgerald	Overweight
2017-11-27	개시	BofA/Merrill	Neutral
2017-11-27	개시	Oppenheimer	Outperform
2017-11-27	개시	Stifel	Buy

모두보기

Spero Therapeutics Inc 주식(SPRO)의 최신 뉴스

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Benzinga

Spero Therapeutics, Inc. (SPRO) Q4 Earnings and Revenues Top Estimates

Zacks Investment Research

Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update

GlobeNewswire Inc.

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire Inc.

Spero Therapeutics Inc (SPRO) 재무 분석

Spero Therapeutics Inc (SPRO) 매출 2024

Spero Therapeutics Inc (SPRO) 순이익 2024

Spero Therapeutics Inc (SPRO) 현금흐름 2024

Spero Therapeutics Inc (SPRO) 주당 순이익 2024